Quantifying the persisting orphan-drug shortage public health crisis in the United States

Quantifying the persisting orphan-drug shortage public health crisis in the United States

Background: Orphan drugs (ODs) are pharmaceuticals manufactured for rare conditions that affect less than 200,000 people in the US. ODs are therefore produced in small quantities to meet sparse demand. Since 2010, OD shortages have become frequent, but no comprehensive, quantitative studies exist. O...

Full description

Bibliographic Details
Main Authors: Szymon Jarosławski, Chiraz Azaiez, Daria Korchagina, Mondher Toumi
Format: Article
Language:English
Published: MDPI AG 2017-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Orphan drugs
rare diseases
drug shortage
public health
Online Access:http://dx.doi.org/10.1080/20016689.2017.1269473

Internet

http://dx.doi.org/10.1080/20016689.2017.1269473

Similar Items